Abstract
Mapping enhancer-target gene regulatory interactions and analyzing enhancer mutations at the level of their target genes and pathways reveal convergence of recurrent enhancer mutations on biological processes involved in tumorigenesis and prognosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have